NASDAQ:AVBP | Income Statement | ArriVent BioPharma, Inc.

Complete source-backed income-statement history.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2026-06-30$42.34M$52.69M-$52.69M-$49.89M-$1.05-$1.0547,606,85747,606,857
2026-03-31$37.62M$46.11M-$46.11M-$43.32M-$0.96-$0.9645,067,65845,067,658
2025-12-31$32.18M$38.82M-$38.82M-$35.54M-$0.78-$0.781,493,6221,493,622
2025-09-30$32.17M$38.32M-$38.32M-$34.98M-$0.83-$0.8341,912,90541,912,905
2025-06-30$27.72M$33.62M-$33.62M-$31.4M-$0.90-$0.9035,006,11435,006,114
2025-03-31$61.29M$66.77M-$66.77M-$64.39M-$1.90-$1.9033,898,87033,898,870
2024-12-31$20.16M$23.71M-$23.71M-$20.63M-$0.61-$0.61748,617748,617
2024-09-30$20.09M$24.23M-$24.23M-$20.56M-$0.61-$0.6133,581,81033,581,810
2024-06-30$21.78M$25.7M-$25.7M-$21.87M-$0.65-$0.6533,502,34733,502,347
2024-03-31$16.98M$20.67M-$20.67M-$17.42M-$0.70-$0.7025,046,53125,046,531
2023-12-31$20.01M$23.12M-$23.12M-$21.19M-$7.69-$7.69191,354191,354
2023-09-30$14.28M$16.72M-$16.72M-$14.4M-$5.52-$5.522,607,1922,607,192
2023-06-30$20.36M$22.58M-$22.58M-$21.57M-$10.79-$10.791,999,7051,999,705
2023-03-31$10.24M$12.17M-$12.17M-$12.17M-$9.45-$9.451,287,5741,287,574

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$153.35M$177.53M-$177.53M-$166.31M-$4.32-$4.3238,462,60038,462,600
2024-12-31$79M$94.31M-$94.31M-$80.49M-$2.56-$2.5631,469,32831,469,328
2023-12-31$64.88M$74.59M-$74.59M-$69.33M-$32.38-$32.382,140,9512,140,951